ReviewEndocrine2026
Infectious complications following thyroid needle procedures: an underrecognized clinical challenge.
Review in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrasound-guided thyroid needle procedures, including fine-needle aspiration (FNA), percutaneous ethanol injection (PEI), and thermal ablation, are widely regarded as safe and effective. Infectious complications are exceptionally rare and may be underrecognized because their presentation can overlap with expected post-procedural inflammatory reactions or aseptic nodule rupture. We performed a focused narrative review of reported infections following thyroid needle procedures, examining their clinical presentation, microbiological findings, risk factors, and management. Published cases indicate that infections may occur after FNA, PEI, and thermal ablation, with considerable heterogeneity in timing, clinical severity, microbiological findings, and therapeutic approach. Reported management strategies range from antibiotic therapy alone to image-guided drainage or surgery, and no standardized treatment pathway is currently available. Early recognition, careful clinical and ultrasound assessment, and management tailored to disease severity are essential to limit progression to abscess formation or local and systemic complications. Greater awareness of these uncommon events may facilitate timely diagnosis and reduce both adverse outcomes and unnecessary interventions.
Indexed as
Identifiers
42570060What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.